Diagnosing gestational diabetes: can expert opinions replace scientific evidence? H. Long Commentary 28 June 2011 Pages: 2211 - 2213
How can we realise the potentially large public health benefit of screening for type 2 diabetes mellitus in south Asians? K. StronksI. G. M. van Valkengoed Commentary Open access 16 July 2011 Pages: 2214 - 2216
Type 2 diabetes: unravelling the interaction between genetic predisposition and lifestyle W. RathmannB. KowallG. Giani Commentary 28 June 2011 Pages: 2217 - 2219
Insulitis in the human endocrine pancreas: Does a viral infection lead to inflammation and beta cell replication? P. In’t Veld Commentary 24 June 2011 Pages: 2220 - 2222
New approaches for the evaluation of renal vascular function in diabetes G. JerumsR. J. MacIsaac Commentary 28 June 2011 Pages: 2223 - 2225
Insulin X10 revisited: a super-mitogenic insulin analogue B. F. HansenP. KurtzhalsD. Russell-Jones Review 03 June 2011 Pages: 2226 - 2231
The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes C. WasserfallK. NeadM. A. Atkinson For Debate 20 July 2011 Pages: 2232 - 2236
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study D. R. WebbL. J. GrayM. J. Davies Article 03 June 2011 Pages: 2237 - 2246
Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus S. SuzukiM. KogaK. Fujieda Article 05 June 2011 Pages: 2247 - 2253
Long-term effects of insulin glargine on the risk of breast cancer S. SuissaL. AzoulayM. Pollak Article 26 May 2011 Pages: 2254 - 2262
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias J. A. JohnsonS. L. BowkerC. A. Marra Article 12 July 2011 Pages: 2263 - 2271
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study The InterAct Consortium Article 30 June 2011 Pages: 2272 - 2282
Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease R. PfisterD. BarnesC. Langenberg Short Communication 03 June 2011 Pages: 2283 - 2287
Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS) R KawasakiS Tanakaon behalf of the Japan Diabetes Complications Study Group Article 01 June 2011 Pages: 2288 - 2294
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes T. S. AhluwaliaE. LindholmL. C. Groop Article 15 May 2011 Pages: 2295 - 2302
Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis L. Y. HanQ. H. WuH. Sun Article 03 June 2011 Pages: 2303 - 2314
UCP2 −866G/A and Ala55Val, and UCP3 −55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study K. XuM. ZhangT. Yang Article 13 July 2011 Pages: 2315 - 2324
Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells F. F. ZhuP. B. ZhangH. Deng Article 14 July 2011 Pages: 2325 - 2336
Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets D. FavreG. NiederhauserA. Abderrahmani Article Open access 06 May 2011 Pages: 2337 - 2346
Deletion of Ia-2 and/or Ia-2β in mice decreases insulin secretion by reducing the number of dense core vesicles T. CaiH. HiraiA. L. Notkins Article 06 July 2011 Pages: 2347 - 2357
Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans K. N. AronisK. N. DiakopoulosC. S. Mantzoros Article 10 June 2011 Pages: 2358 - 2367
Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome H. ZhangX. ChenM. R. Sairam Article 19 June 2011 Pages: 2368 - 2380
Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice J. MuG. JiangB. B. Zhang Article 22 June 2011 Pages: 2381 - 2391
Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet P. M. JamiesonM. E. CleasbyW. W. Vale Article Open access 11 June 2011 Pages: 2392 - 2403
Quantitative EEG in type 1 diabetic adults with childhood exposure to severe hypoglycaemia: a 16 year follow-up study B. O. ÅsvoldT. SandM. R. Bjørgaas Short Communication Open access 03 June 2011 Pages: 2404 - 2408
Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy M. B. SasongkoT. Y. WongJ. J. Wang Article 29 May 2011 Pages: 2409 - 2416
Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes A. WillcoxS. J. RichardsonN. G. Morgan Short Communication 20 May 2011 Pages: 2417 - 2420
Non-invasive investigation of kidney disease in type 1 diabetes by magnetic resonance imaging P. E. ThelwallR. TaylorS. M. Marshall Article 01 May 2011 Pages: 2421 - 2429
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes R. M. BrunoE. DaghiniA. Solini Article 16 April 2011 Pages: 2430 - 2439
Wld S protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice S. S. ZhuY. RenQ. Chen Article 08 July 2011 Pages: 2440 - 2450
Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto–Kakizaki (GK) rat M-H. GiroixJ-C. IrmingerF. Homo-Delarche Article 10 July 2011 Pages: 2451 - 2462
Plasma procalcitonin and risk of type 2 diabetes in the general population A. AbbasiE. CorpeleijnS. J. L. Bakker Research Letter 15 June 2011 Pages: 2463 - 2465
Could there be a role for metformin in type 1 and type 2 diabetic pregnancies? I. PernicovaM. J. PrasaiE. M. Scott Letter 16 July 2011 Pages: 2466 - 2467
Risk scores for predicting type 2 diabetes: using the optimal tool M. AlssemaD. Vistisenfor the DETECT-2 collaboration Letter 10 June 2011 Pages: 2468 - 2470
Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data. Reply to Uusitupa M, Lindström J, Tuomilehto J [letter] A. E. BuykenP. MitchellJ. Brand-Miller Letter 03 July 2011 Pages: 2471 - 2472
Erratum to: Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes R. M. BrunoE. DaghiniA. Solini Erratum 06 July 2011 Pages: 2473 - 2473
Erratum to: mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans K. OmoriM. MitsuhashiY. Mullen Erratum 06 July 2011 Pages: 2474 - 2474
Erratum to: Retraction of ‘Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats’ Y. HattoriK. AkimotoK. Kasai Retraction Note 17 May 2011 Pages: 2475 - 2475
